Literature DB >> 10586908

The contribution of host-related factors to low cure rates of praziquantel for the treatment of Schistosoma mansoni in Senegal.

L van Lieshout1, F F Stelma, F Guissé, S T Falcao Ferreira, K Polman, G J van Dam, M Diakhate, S Sow, A Deelder, B Gryseels.   

Abstract

Surprisingly low cure rates were repeatedly observed after treatment with a standard dosage of praziquantel in a recently established Schistosoma mansoni focus in northern Senegal. In 4 discrete cohorts from the same population, cure rates were 18-36% and egg count reduction rates were 77-88%. Data and material of 920 compliant subjects from all 4 cohorts were further analyzed to identify possible host-related factors associated with low cure rates. The lowest cure rates were found in the highest egg count groups. However, in low and moderate egg count groups, drug efficacy was also below normal values. Cure rates were similar in males and females, showed no seasonal variation, and were independent of previous praziquantel treatment. They were significantly higher in adults than in children, also after allowing for intensity of infection. Individual water contact behavior and specific humoral immune responses were examined in 2 extreme subgroups, either without significant egg count reduction or showing complete parasitologic cure. There was no significant difference in frequency and duration of water contact between those individuals with complete cure and those that showed little effect of praziquantel treatment. Levels of IgG, IgG1, IgG3, IgG4, IgM, and IgE against adult worm antigen were not different between the 2 subgroups. Thus, the abnormally frequent failure of treatment observed in this focus could not be associated with any host-related factor, other than age and pretreatment egg counts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586908     DOI: 10.4269/ajtmh.1999.61.760

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

Review 1.  Drug resistance in human helminths: current situation and lessons from livestock.

Authors:  S Geerts; B Gryseels
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 2.  Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.

Authors:  Jürg Utzinger; Jennifer Keiser; Xiao Shuhua; Marcel Tanner; Burton H Singer
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

3.  Factors affecting the anthelmintic efficacy of papaya latex in vivo: host sex and intensity of infection.

Authors:  Wenceslaus Luoga; Fadlul Mansur; Ann Lowe; Ian R Duce; David J Buttle; Jerzy M Behnke
Journal:  Parasitol Res       Date:  2015-04-10       Impact factor: 2.289

4.  Phage displaying peptides mimic schistosoma antigenic epitopes selected by rat natural antibodies and protective immunity induced by their immunization in mice.

Authors:  Min Wang; Xin-Yuan Yi; Xian-Ping Li; Dong-Ming Zhou; McReynolds Larry; Xian-Fang Zeng
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

Review 5.  Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges.

Authors:  Rashad Abdul-Ghani; Naguiba Loutfy; Amel el-Sahn; Azza Hassan
Journal:  Parasitol Res       Date:  2009-03-03       Impact factor: 2.289

6.  Population level changes in schistosome-specific antibody levels following chemotherapy.

Authors:  Mizuho Fukushige; Francisca Mutapi; Mark E J Woolhouse
Journal:  Parasite Immunol       Date:  2019-01       Impact factor: 2.280

7.  Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya.

Authors:  Carla L Black; Michelle L Steinauer; Pauline N M Mwinzi; W Evan Secor; Diana M S Karanja; Daniel G Colley
Journal:  Trop Med Int Health       Date:  2009-02-14       Impact factor: 2.622

8.  Evidence of long term benefit of morbidity reduction due to praziquantel treatment against schistosoma mansoni in kigungu fishing village in entebbe, Uganda.

Authors:  Emmanuel I Odongo-Aginya; Fk Kironde; Mi Lyazi; Harman Sempewo; Rodrigo Correa Oliveira
Journal:  Afr J Infect Dis       Date:  2011
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.